eXIthera
0 followers
‌
eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation, preventing thrombosis without an increased risk of bleeding.
Industries
Headquarters
Employees
Links
Org chart
Neil J. Hayward
CEO, President, & Co-Founder
Neil J. Hayward
Collapse
Michael Kurz
VP, Translational Medicine & Medical Affairs
Paula M. Bokesch
Head, Clinical Development
Bert L. Chenard
Head, Chemistry
Priya Jambhekar
Head, Regulatory Affairs
Andy Hu
Head, Corporate & Business Development
William Koster
Director (Chairman)
Similar companies
AbbVie
152 followers
Incyte
14 followers
Novavax
7 followers
Recursion Pharmaceuticals
6 followers
Amgen
181 followers
PTC Therapeutics
8 followers
Amneal Pharmaceuticals
5 followers
Bristol-Myers Squibb
165 followers
Thermo Fisher Scientific
143 followers
Genentech
144 followers
Gilead Sciences
121 followers
Discover companies